| Stephen W Castro, MD | |
|
7455 W Washington Ave Ste 301, Las Vegas, NV 89128-4340 | |
| (877) 562-5227 | |
| (702) 938-9954 |
| Full Name | Stephen W Castro |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 12 Years |
| Location | 7455 W Washington Ave Ste 301, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912273657 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 17169 (Nevada) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
A seriously ill baby girl has been given a lifeline by a high court in Britain.
Experts at the University of Warwick have produced microscopic footage of the potentially deadly E. coli bacteria being wiped out in just two hours on an antimicrobial treated ‘intelligent' surface.
A new study shows that genetic mutations could be detected in one in 40 women diagnosed with breast cancer before the age of 65 years. The study from Stanford researchers, titled "Prevalence of Pathogenic Variants in Cancer Susceptibility Genes Among Women With Postmenopausal Breast Cancer," was published as a research letter 10th March in the journal JAMA.
Sermo (http://www.sermo.com), the world's largest online physician's community, today announced a new Sermo Event(TM) Report assessing physician perception of FDA's "refuse to file" (RTF) letter on EMD Serono's Cladribine tablets and its potential impact, if any, on Novartis' oral MS agent in development; Fingolimod. Cladribine is expected to be one of the first oral agents to be approved for the treatment of relapsing and remitting multiple sclerosis.
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company has engaged in preliminary discussions to launch a pilot of its syringe locking device, with a major hospital in Jerusalem.
› Verified 9 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
A seriously ill baby girl has been given a lifeline by a high court in Britain.
Experts at the University of Warwick have produced microscopic footage of the potentially deadly E. coli bacteria being wiped out in just two hours on an antimicrobial treated ‘intelligent' surface.
A new study shows that genetic mutations could be detected in one in 40 women diagnosed with breast cancer before the age of 65 years. The study from Stanford researchers, titled "Prevalence of Pathogenic Variants in Cancer Susceptibility Genes Among Women With Postmenopausal Breast Cancer," was published as a research letter 10th March in the journal JAMA.
Sermo (http://www.sermo.com), the world's largest online physician's community, today announced a new Sermo Event(TM) Report assessing physician perception of FDA's "refuse to file" (RTF) letter on EMD Serono's Cladribine tablets and its potential impact, if any, on Novartis' oral MS agent in development; Fingolimod. Cladribine is expected to be one of the first oral agents to be approved for the treatment of relapsing and remitting multiple sclerosis.
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company has engaged in preliminary discussions to launch a pilot of its syringe locking device, with a major hospital in Jerusalem.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen W Castro, MD 11025 Rca Center Dr Ste 300, Palm Beach Gardens, FL 33410-4269 Ph: (561) 383-3820 | Stephen W Castro, MD 7455 W Washington Ave Ste 301, Las Vegas, NV 89128-4340 Ph: (877) 562-5227 |
News Archive
A seriously ill baby girl has been given a lifeline by a high court in Britain.
Experts at the University of Warwick have produced microscopic footage of the potentially deadly E. coli bacteria being wiped out in just two hours on an antimicrobial treated ‘intelligent' surface.
A new study shows that genetic mutations could be detected in one in 40 women diagnosed with breast cancer before the age of 65 years. The study from Stanford researchers, titled "Prevalence of Pathogenic Variants in Cancer Susceptibility Genes Among Women With Postmenopausal Breast Cancer," was published as a research letter 10th March in the journal JAMA.
Sermo (http://www.sermo.com), the world's largest online physician's community, today announced a new Sermo Event(TM) Report assessing physician perception of FDA's "refuse to file" (RTF) letter on EMD Serono's Cladribine tablets and its potential impact, if any, on Novartis' oral MS agent in development; Fingolimod. Cladribine is expected to be one of the first oral agents to be approved for the treatment of relapsing and remitting multiple sclerosis.
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company has engaged in preliminary discussions to launch a pilot of its syringe locking device, with a major hospital in Jerusalem.
› Verified 9 days ago
Mrs. June Durkee Sigman, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 7455 W Washington Ave Ste 301, Las Vegas, NV 89128 Phone: 877-562-5227 Fax: 702-732-2310 | |
Dr. Bert G. Dougherty, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3059 S Maryland Pkwy, 100, Las Vegas, NV 89109 Phone: 702-732-3441 Fax: 702-732-2310 | |
Dr. David Patrick Marmaduke, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3059 S Maryland Pkwy Ste 100, Las Vegas, NV 89109 Phone: 702-732-3441 Fax: 702-732-2310 | |
Narciss Mobini, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 4230 Burnham Ave, Las Vegas, NV 89119 Phone: 702-733-7866 Fax: 702-792-1319 | |
Mr. Jonathan Howard Hughes, MD PHD Pathology Medicare: Accepting Medicare Assignments Practice Location: 3059 S Maryland Pkwy Ste 100, Las Vegas, NV 89109 Phone: 702-732-3441 Fax: 702-732-2310 | |
Peter Aylward Scully, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 4230 Burnham Avenue, Las Vegas, NV 89119 Phone: 702-733-7866 Fax: 702-792-1319 | |
Jonathan Stuart Strauss, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 4230 Burnham Ave, Las Vegas, NV 89119 Phone: 702-733-7866 Fax: 702-792-1319 |